|
US3126375A
(en)
|
|
1964-03-24 |
|
Chioacyl |
|
GB933867A
(en)
|
1958-12-08 |
1963-08-14 |
American Cyanamid Co |
Fluorinated steroids
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
DE3546806C2
(enExample)
|
1985-03-30 |
1991-03-28 |
Marc Genf/Geneve Ch Ballivet |
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
DE3889853D1
(de)
|
1987-11-05 |
1994-07-07 |
Hybritech Inc |
Polysaccharidmodifizierte Immunglobuline mit reduziertem immunogenem Potential oder verbesserter Pharmakokinetik.
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5010176A
(en)
|
1988-11-10 |
1991-04-23 |
Eli Lilly And Company |
Antibody-drug conjugates
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
JP2938569B2
(ja)
|
1990-08-29 |
1999-08-23 |
ジェンファーム インターナショナル，インコーポレイティド |
異種免疫グロブリンを作る方法及びトランスジェニックマウス
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
GB9109645D0
(en)
|
1991-05-03 |
1991-06-26 |
Celltech Ltd |
Recombinant antibodies
|
|
US6284471B1
(en)
|
1991-03-18 |
2001-09-04 |
New York University Medical Center |
Anti-TNFa antibodies and assays employing anti-TNFa antibodies
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
|
WO1993011794A1
(en)
|
1991-12-13 |
1993-06-24 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
ATE172739T1
(de)
|
1993-04-02 |
1998-11-15 |
Byk Gulden Lomberg Chem Fab |
Neue prednisolonderivate
|
|
WO1994025478A1
(en)
|
1993-04-29 |
1994-11-10 |
Instytut Farmaceutyczny |
16α,17α-ACETAL GLUCOCORTICOSTEROIDAL DERIVATIVES
|
|
PT749438E
(pt)
|
1994-03-09 |
2001-05-31 |
Byk Gulden Lomberg Chem Fab |
Novos compostos sililo e sua utilizacao
|
|
JP2749778B2
(ja)
|
1994-09-05 |
1998-05-13 |
日清食品株式会社 |
トリアムシノロン誘導体
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US7264963B1
(en)
|
1995-08-18 |
2007-09-04 |
Morphosys Ag |
Protein(poly)peptide libraries
|
|
ES2176484T3
(es)
|
1995-08-18 |
2002-12-01 |
Morphosys Ag |
Bancos de proteinas/(poli)peptidos.
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
BRPI9707379C8
(pt)
|
1996-02-09 |
2017-12-12 |
Abbott Biotech Ltd |
composições farmacêuticas compreendendo anticorpo humano recombinante geneticamente engenheirado, e anticorpo humano recombinante geneticamente engenheirado.
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
DE19635498A1
(de)
|
1996-09-03 |
1998-03-26 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Epimerenanreicherung
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US8383081B2
(en)
|
1999-05-10 |
2013-02-26 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods of use
|
|
ATE482275T1
(de)
|
1999-07-02 |
2010-10-15 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
GB0013810D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Celltech Chiroscience Ltd |
Biological products
|
|
DE10055820C1
(de)
|
2000-11-10 |
2002-07-25 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Herstellung eines Glucocorticoids
|
|
HU228432B1
(hu)
|
2000-11-10 |
2013-03-28 |
Nycomed Gmbh |
Eljárás 16,17-(ciklohexilmetilén)-bisz(oxi)-11,21-dihidroxi-pregna-1,4-dién-3,20-dion elõállítására transz-ketálozással
|
|
CA2385745C
(en)
|
2001-06-08 |
2015-02-17 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
US7595378B2
(en)
|
2001-06-13 |
2009-09-29 |
Genmab A/S |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
|
|
US20060073141A1
(en)
|
2001-06-28 |
2006-04-06 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
|
JP2005538706A
(ja)
|
2001-07-12 |
2005-12-22 |
ジェファーソン フーテ， |
スーパーヒト化抗体
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
CA2462930C
(en)
|
2001-10-10 |
2012-07-10 |
Shawn De Frees |
Remodeling and glycoconjugation of peptides
|
|
RU2004117915A
(ru)
|
2001-11-12 |
2005-05-10 |
Мерк Патент ГмбХ (DE) |
Модифицированное анти-tnf альфа антитело
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
WO2004017904A2
(en)
|
2002-08-23 |
2004-03-04 |
The Mclean Hospital Corporation |
Corticosteroid conjugates and uses thereof
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
EP1567113A4
(en)
|
2002-10-24 |
2006-11-08 |
G & R Pharmaceuticals Llc |
ANTIFUNGAL PREPARATIONS
|
|
KR20050059332A
(ko)
|
2002-11-07 |
2005-06-17 |
이뮤노젠 아이엔씨 |
항-씨디33 항체와 이를 이용한 급성 골수성 백혈병의치료방법
|
|
JP2006515847A
(ja)
|
2002-12-13 |
2006-06-08 |
ニューロジェン・コーポレーション |
カプサイシン受容体調節剤としてのカルボン酸、ホスフェート又はホスホネート置換キナゾリン−４−イルアミン類縁体
|
|
JP2006516636A
(ja)
|
2003-01-30 |
2006-07-06 |
メディミューン，インコーポレーテッド |
抗インテグリンαｖβ３抗体製剤及びその用途
|
|
MY143936A
(en)
|
2003-03-27 |
2011-07-29 |
Nycomed Gmbh |
Process for preparing crystalline ciclesonide with defined particle size
|
|
WO2005044759A2
(en)
|
2003-08-14 |
2005-05-19 |
Sun Pharmaceutical Industries Limited |
Acetalization process for preparation of steroid compounds
|
|
ES2452691T5
(es)
|
2003-09-16 |
2022-09-14 |
Covis Pharma Gmbh |
Uso de ciclesonida para el tratamiento de enfermedades respiratorias
|
|
WO2005028495A1
(en)
|
2003-09-24 |
2005-03-31 |
Glaxo Group Limited |
Anti-inflammatory glucocorticoids
|
|
WO2005041865A2
(en)
|
2003-10-21 |
2005-05-12 |
Igf Oncology, Llc |
Compounds and method for treating cancer
|
|
EP1685131B1
(en)
|
2003-11-13 |
2007-03-07 |
F. Hoffmann-La Roche AG |
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
|
|
BRPI0417771A
(pt)
|
2003-12-19 |
2007-04-17 |
Bristol Myers Squibb Co |
heterociclos azabicìclicos como moduladores de receptor canabinóides
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
RU2390330C2
(ru)
|
2003-12-31 |
2010-05-27 |
Сайдекс, Инк. |
Ингаляционная препаративная форма, содержащая простой сульфоалкиловый эфир гамма-циклодекстрина и кортикостероид
|
|
GB0402797D0
(en)
|
2004-02-09 |
2004-03-10 |
Novartis Ag |
Organic compounds
|
|
ES2533695T3
(es)
|
2004-03-02 |
2015-04-14 |
Seattle Genetics, Inc. |
Anticuerpos cargados parcialmente y métodos para su conjugación
|
|
US20080187954A1
(en)
|
2004-03-10 |
2008-08-07 |
Lonza Ltd. |
Method For Producing Antibodies
|
|
DK2471813T3
(en)
|
2004-07-15 |
2015-03-02 |
Xencor Inc |
Optimized Fc variants
|
|
AU2005279347A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
HRP20120171T1
(hr)
|
2004-09-03 |
2012-03-31 |
Genentech |
Humanizirani anti-beta 7 antagonisti i njihove uporabe
|
|
US20080027034A1
(en)
|
2004-09-10 |
2008-01-31 |
Shah Tushar P |
Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
CA2587589A1
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
WO2006097458A1
(en)
|
2005-03-15 |
2006-09-21 |
Nycomed Gmbh |
Novel combination
|
|
WO2006110593A2
(en)
|
2005-04-07 |
2006-10-19 |
Macrogenics, Inc. |
Biological targets for the diagnosis, treatment and prevention of cancer
|
|
EP1712220A1
(en)
|
2005-04-15 |
2006-10-18 |
PARI GmbH Spezialisten für effektive Inhalation |
Pharmaceutical aerosol composition
|
|
WO2006135479A2
(en)
|
2005-05-10 |
2006-12-21 |
Angiotech International Ag |
Anti-scarring agents, therapeutic compositions, and use thereof
|
|
EP1893220A4
(en)
|
2005-06-14 |
2011-06-15 |
Gilead Sciences Inc |
SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PROMO PRODUCTS CONSISTING OF STEROIDS AND BETA-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
|
|
PT1912677E
(pt)
|
2005-06-20 |
2013-12-23 |
Psma Dev Company L L C |
Conjugados de anticorpos contra psma-fármaco
|
|
WO2007054974A2
(en)
|
2005-09-28 |
2007-05-18 |
Arch Pharmalab Limited |
A green chemistry process for the preparation of pregnadiene esters
|
|
US9101670B2
(en)
|
2006-04-07 |
2015-08-11 |
Nektar Therapeutics |
Conjugates of an anti-TNF-α antibody
|
|
WO2008015696A2
(en)
|
2006-05-23 |
2008-02-07 |
Cadila Healthcare Limited |
Process for preparing ciclesonide
|
|
US8524865B2
(en)
|
2006-05-30 |
2013-09-03 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
EP2392584A1
(en)
|
2006-09-19 |
2011-12-07 |
Cipla Limited |
Crystalline Ciclesonide Methanol Solvate Form C
|
|
WO2008052350A1
(en)
|
2006-11-03 |
2008-05-08 |
Qlt Inc. |
Photodynamic therapy for the treatment of hidradenitis suppurativa
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
NO331891B1
(no)
|
2007-03-20 |
2012-04-30 |
Clavis Pharma Asa |
Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
|
|
UA100120C2
(en)
|
2007-04-03 |
2012-11-26 |
Анадис Фармасьютикалз, Инк. |
5,6-dihydro-1h-pyridin-2-one compounds
|
|
CN101795565A
(zh)
|
2007-06-28 |
2010-08-04 |
锡德克斯药物公司 |
皮质类固醇水溶液的鼻部和眼部给药
|
|
EP2225256B1
(en)
*
|
2007-11-30 |
2013-01-09 |
Pfizer Limited |
Novel glucocorticoid receptor agonists
|
|
CN101970452A
(zh)
|
2007-12-21 |
2011-02-09 |
先灵公司 |
C20-c21取代的糖皮质激素受体激动剂
|
|
WO2009085880A2
(en)
|
2007-12-21 |
2009-07-09 |
Schering Corporation |
C-21 thioethers as glucocorticoid receptor agonists
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
KR20110005236A
(ko)
|
2008-02-27 |
2011-01-17 |
아스트라제네카 아베 |
１６ 알파, １７ 알파-아세탈 글루코코르티코스테로이드 유도체 및 그의 용도
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
EP2262823B1
(en)
|
2008-03-13 |
2013-01-23 |
Farmabios S.p.A. |
Process for the preparation of pregnane derivatives
|
|
EP2294077A1
(en)
|
2008-06-10 |
2011-03-16 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
EP2300052A4
(en)
|
2008-06-16 |
2012-11-14 |
Immunogen Inc |
NEW SYNERGISTIC EFFECTS
|
|
BRPI0914629A2
(pt)
|
2008-06-24 |
2019-09-24 |
Irm Llc |
compostos e métodos para a modulação de receptores acoplados à proteína g
|
|
WO2010054158A2
(en)
|
2008-11-07 |
2010-05-14 |
Auspex Pharmaceuticals, Inc. |
Steroid modulators of glucocorticoid receptor
|
|
WO2010065882A1
(en)
|
2008-12-04 |
2010-06-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
EP3482769B1
(en)
|
2008-12-19 |
2024-05-29 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
|
WO2010104187A1
(ja)
|
2009-03-09 |
2010-09-16 |
三笠製薬株式会社 |
ステロイド化合物
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
SG175738A1
(en)
|
2009-05-29 |
2011-12-29 |
Pfizer Ltd |
Novel glucocorticoid receptor agonists
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
US10584181B2
(en)
|
2009-12-04 |
2020-03-10 |
Genentech, Inc. |
Methods of making and using multispecific antibody panels and antibody analog panels
|
|
EP2509630A4
(en)
|
2009-12-09 |
2013-07-17 |
Immunomedics Inc |
SYSTEM FOR PROCESSING CYTOTOXIC REMEDIES THROUGH BISPECIFIC ANTIBODY TARGET
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
CN102167741B
(zh)
|
2010-02-25 |
2014-05-14 |
上海百迈博制药有限公司 |
一种全人源抗TNF-α单克隆抗体、其制备方法及用途
|
|
KR20130010123A
(ko)
|
2010-04-07 |
2013-01-25 |
아비에 인코포레이티드 |
ＴＮＦ-α 결합 단백질
|
|
KR101860963B1
(ko)
|
2010-04-23 |
2018-05-24 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
|
CN103037903A
(zh)
|
2010-05-18 |
2013-04-10 |
天蓝制药公司 |
用于治疗自身免疫性疾病或其它疾病的组合物和方法
|
|
RS57543B1
(sr)
|
2010-06-03 |
2018-10-31 |
Abbvie Biotechnology Ltd |
Primene i kompozicije za lečenje hidradenitis suppurativa (hs)
|
|
SG188944A1
(en)
|
2010-06-24 |
2013-05-31 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
US8574630B2
(en)
|
2010-09-22 |
2013-11-05 |
Map Pharmaceuticals, Inc. |
Corticosteroid particles and method of production
|
|
AR084210A1
(es)
|
2010-12-08 |
2013-05-02 |
Abbott Lab |
PROTEINAS DE UNION AL TNF-a
|
|
WO2012082947A1
(en)
|
2010-12-16 |
2012-06-21 |
Irm Llc |
Compounds and compositions as tgr5 agonists
|
|
EP2659642A1
(en)
|
2010-12-29 |
2013-11-06 |
Nokia Siemens Networks Oy |
A method and apparatus for transmitting an identity
|
|
WO2012131053A1
(en)
|
2011-03-30 |
2012-10-04 |
Ablynx Nv |
Methods of treating immune disorders with single domain antibodies against tnf-alpha
|
|
JP5827511B2
(ja)
|
2011-07-25 |
2015-12-02 |
新日鉄住金エンジニアリング株式会社 |
石炭ガスの製造方法およびメタンの製造方法
|
|
IN2014CN03936A
(enExample)
|
2011-10-24 |
2015-09-04 |
Abbvie Inc |
|
|
HK1200321A1
(en)
|
2011-10-24 |
2015-08-07 |
Abbvie Inc. |
Bispecific immunobinders directed against tnf and il-17
|
|
US20130115269A1
(en)
|
2011-11-04 |
2013-05-09 |
Henry John Smith |
Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases
|
|
US20140359902A1
(en)
|
2011-12-16 |
2014-12-04 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
|
US9109005B2
(en)
|
2012-02-23 |
2015-08-18 |
Boehringer Ingelheim International Gmbh |
Method for manufacturing of ciclesonide
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
CN103421075B
(zh)
|
2012-05-16 |
2017-07-28 |
上海特化医药科技有限公司 |
孕烷衍生物16,17‑缩醛(酮)的制备方法
|
|
EP2855745A4
(en)
|
2012-06-01 |
2016-01-20 |
Momenta Pharmaceuticals Inc |
METHODS RELATING TO ADALIMUM AB
|
|
US10066019B2
(en)
|
2012-10-12 |
2018-09-04 |
Agency For Science, Technology And Research |
Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics
|
|
JP6133431B2
(ja)
|
2012-11-24 |
2017-05-24 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
|
|
US9107960B2
(en)
|
2012-12-13 |
2015-08-18 |
Immunimedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
|
EP2934544B1
(en)
|
2012-12-21 |
2018-11-07 |
Boehringer Ingelheim Vetmedica GmbH |
Pharmaceutical formulation comprising ciclesonide
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
CN105189550A
(zh)
*
|
2013-03-15 |
2015-12-23 |
艾伯维公司 |
改善的tnf结合蛋白
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
RU2015145491A
(ru)
*
|
2013-03-27 |
2017-05-16 |
ОЛЕДВоркс ГмбХ |
МОДЕРНИЗИРОВАННЫЙ ИСТОЧНИК СВЕТА НА ОРГАНИЧЕСКИХ СВЕТОИЗЛУЧАЮЩИХ ДИОДАХ (ОСИДах)
|
|
EP3049443A4
(en)
|
2013-09-27 |
2017-04-05 |
Immunomedics, Inc. |
Anti-trop-2 antibody-drug conjugates and uses thereof
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
US10464955B2
(en)
|
2014-02-28 |
2019-11-05 |
Hangzhou Dac Biotech Co., Ltd. |
Charged linkers and their uses for conjugation
|
|
EP3125943A4
(en)
*
|
2014-04-04 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
WO2016003869A1
(en)
|
2014-06-30 |
2016-01-07 |
Immunomedics, Inc. |
Antibodies reactive with an epitope located in the n-terminal region of muc5ac comprising cysteine-rich subdomain 2 (cys2)
|
|
AU2015316710B2
(en)
|
2014-09-19 |
2020-07-23 |
Oxular Limited |
Ophthalmic drug compositions
|
|
WO2016120891A1
(en)
|
2015-01-30 |
2016-08-04 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
JP2016190798A
(ja)
|
2015-03-31 |
2016-11-10 |
三笠製薬株式会社 |
アレルギー性鼻炎治療用局所点鼻薬
|
|
JP2017066075A
(ja)
|
2015-09-30 |
2017-04-06 |
三笠製薬株式会社 |
リウマチ治療薬
|
|
LT3464318T
(lt)
*
|
2016-06-02 |
2021-06-25 |
Abbvie Inc. |
Gliukokortikoidų receptorių agonistas ir jo imunokonjugatai
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|
|
MX394528B
(es)
|
2016-11-08 |
2025-03-24 |
Regeneron Pharma |
Esteroides y conjugados de proteinas de los mismos.
|